Neurocrine Biosciences volatility elevated into data Neurocrine Biosciences overall option implied volatility of 73 is above its 26-week average of 55 according to Track Data, suggesting larger price movement into the expected release of Phase IIb data in tardive dyskinesia in May and July.
News For NBIX From The Last 14 Days
Check below for free stories on NBIX the last two weeks.
